The study drug is exploring a potential new treatment for Allergic Inflammatory Disorders
This study is exploring a new treatment option for conditions related to the immune system, such as Eosinophilic oesophagitis, respiratory conditions such as Asthma, and Atopic Dermatitis.
This study is a crucial step before testing the study medication in patients. By participating, you will contribute to research that could lead to more accessible and effective treatments for Immune-Related conditions. Your involvement will help researchers determine the best way to administer this potential therapy, ensuring it is both practical and widely available.
Call us on 1300 570 105 to discuss your eligibility today!